Read More Pharma Industry News HUTCHMED’s ATTC platform and fruquintinib combo data headline 2025 R&D updates Find out how HUTCHMED’s new ATTC platform and strong late-stage trial results could reshape its cancer drug pipeline and investor outlook today. bySoujanya RaviNovember 3, 2025